SEC Form 4 · accession 0001209191-17-005315
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jan Mattsson
Officer — Chief Operating Officer
Period of report
Jan 20, 2017
Accepted (ET)
Jan 24, 2017 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $19.19 | Jan 20, 2017 | A | 20,000 | A | — | Jan 19, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1This option will vest and become exercisable in equal installments on the last day of 16 consecutive calendar quarters beginning with March 31, 2017 and ending on December 31, 2020.